News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Erman Akkus: Tremelimumab plus durvalumab (STRIDE) in HCC-HIMALAYA update
Photo taken from Erman Akkus/X
Feb 21, 2024, 18:13

Erman Akkus: Tremelimumab plus durvalumab (STRIDE) in HCC-HIMALAYA update

Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter:

“Tremelimumab plus durvalumab (STRIDE) in HCC:
HIMALAYA update

  • 1171 patients, first line, STRIDE or Durva or sorafenib
  • STRIDE versus sorafenib, OS: HR 0.78 (0.67-0.92
  • durvalumab versus sorafenib, OS: HR 0.86 (0.74-1.01)
  • long-term OS benefit of STRIDE versus sorafenib
  • Durvalumab maintained OS noninferiority to sorafenib.”

Erman Akkus: Tremelimumab plus durvalumab (STRIDE) in HCC-HIMALAYA update

Proceed to the article.
Source: Erman Akkus/X

Ankara University Annals of Oncology cancer Durvalumab Erman Akkus ESMO HCC hepatocellular carcinoma HIMALAYA study OncoDaily Oncology sorafenib Tremelimumab
Special Coverage
Blog
Dec 21, 2024, 14:10
Arif Kamal: Ensuring all people have access to the cancer navigation services that will help them live more and better days
Blog
Dec 21, 2024, 14:06
The Accelerate 2025 Annual Conference Agenda Is Here!
Blog
Dec 21, 2024, 14:03
Pioneer the future of discovery and innovation with a fully funded Bicentenary PhD Studentship at The University of Manchester
Blog
Dec 21, 2024, 14:00
NCI Division of Cancer Prevention - DHT Derived Biomarkers and COAs for Remote Monitoring and Endpoint Development
Blog
Dec 21, 2024, 13:51
The ESMO President Letter emphasises the importance of collective action to shape the future of oncology
Blog
Dec 21, 2024, 13:48
Overcoming recurrence: How research is bringing new hope for breast cancer patients - The Institute of Cancer Research
Blog
Dec 21, 2024, 13:46
IARC - Cancer Incidence in Five Continents, Vol XII
Blog
Dec 21, 2024, 13:43
National University Cancer Institute, Singapore clinicians had the exciting opportunity to present their work at the ESMO Asia 2024
Blog
Dec 21, 2024, 13:40
UICC - Welcoming the newest member, The World Hepatitis Alliance
Blog
Dec 21, 2024, 13:35
Pediatric Cancer and Blood Disorders Center of Armenia - Prioritizing the continuous education and knowledge exchange of the medical staff
Blog
Dec 21, 2024, 13:33
SIOP Europe - International Childhood Cancer Day 2025
Blog
Dec 21, 2024, 13:29
Canadian Cancer Society - How 5 organizations are working to take on cancer’s biggest issues